Review a webinar workshop focused on GLP-1s, Psychedelics, and Pharmacokinetics: Navigating New Frontiers in Clinical Practice
Important Webinar Details
- Includes access to the recording of the webinar workshop as well as downloadable PDF slides
- The workshop will consist of a ~60 min lecture, 20-30 min case review and discussion, followed by 10 min Q&A period
- There will be no refunds issued for the webinar
Workshop Overview:
GLP-1 (Glucagon like peptide 1) receptor agonists and dual incretin mimetics (e.g., semaglutide, tirzepatide) have surged in popularity across metabolic medicine, diabetes care, and obesity management. At the same time, interest in psychedelic-assisted therapies is accelerating, with psilocybin, MDMA, and other agents gaining popularity for mental health conditions.
But here’s the challenge, GLP-1s fundamentally alter gastric emptying and satiety. This can lead to shifts in the pharmacokinetics of co-administered drugs or medications, and therefore pharmacodynamics of the subjective effects, of orally administered psychoactives. For persons guiding patients in mental health contexts whom are approaching psychedelics, understanding these intersections may be critical to optimizing subjective effects and subsequent benefits of experiences.
In this webinar our formal learning objectives are to:
- Describe incretin mimetic pharmacology with a focus on GLP-1 receptor agonists
- Define pharmacokinetic drug interactions and their impacts of pharmacodynamics of various medications
- Examine how GLP-1 receptor agonists could impact effects of various psychedelic substances
- Review case studies and clinical approaches to management of GLP-1 agents in the context of psychedelic use
Registration will trigger an email with the webinar recording page linked and you will be taken directly there upon purchase. It is recommended to save the webinar landing page link to easily return.
Host Information
Dr. Ben Malcolm, PharmD, MPH - Founder of Spirit Pharmacist
Psychopharmacology Consultant and Psychedelic Educator
Dr. Ben Malcolm earned his bachelor’s degree (BS) in pharmacology at the University of California at Santa Barbara, prior to his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. He then completed post-graduate residencies in Acute Care at Scripps Mercy Hospital and Psychiatric Pharmacy at the University of California at San Diego Health.
After residency he passed his exam to become Board Certified in Psychiatric Pharmacy (BCPP). He began his career as an Assistant Clinical Professor at Western University of Health Sciences (WUHS), College of Pharmacy before transitioning to his current entrepreneurial role as a Psychopharmacology Consultant, Psychedelic Educator, and Founder of https://www.spiritpharmacist.com
Ben envisions a society in which access to psychedelic drugs in a variety of safe and supported settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness. His focus is on the intersection between psychiatric medications and psychedelic therapies. He has given several Continuing Education presentations to pharmacists and other healthcare professionals as well as published over a dozen articles in peer-reviewed literature relating to psychedelics or psychiatric medications.
His vision guides his clinical and education service-related professional activity.
Webinar Disclaimer
This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.